Home Markets Aurobindo Pharma Outperforms Expectations with Strong Q4, Eyes Robust Growth Ahead

Aurobindo Pharma Outperforms Expectations with Strong Q4, Eyes Robust Growth Ahead

May 28, 2024 comments off

Original source: https://www.investing.com/news/stock-market-news/aurobindo-pharma-outperforms-expectations-with-strong-q4-eyes-robust-growth-ahead-3457980

You May Also Like

Elon Musk’s xAI Holdings in talks to raise $20 billion from investors, Bloomberg News reports

Exclusive-China’s Leapmotor to supply EV platform to Hongqi

Nissan to end vehicle production at Wuhan plant-Yomiuri

Rubio replaces top US diplomat for Europe with former Senate staffer, consultant

US FTC offers employees financial incentives to quit

Unilever says it didn’t seek Ben & Jerry’s CEO ouster, urges lawsuit be dismissed